In 2025, researchers created a stable version called diAcCA, and early lab results are promising. The compound improved ...

A new Alzheimer’s drug, lecanemab, may slow disease progression and offer patients up to four extra years of stable health.

The Alzheimer's Association international conference highlighted the roles exercise, lead exposure, blood tests and food ...

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

The FDA cleared the use of the first approved blood test that can help diagnose Alzheimer’s disease. Learn more from U of U ...

Researchers at the Carney Institute for Brain Science have identified electrical activity in the brain that could predict ...

Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% ...

In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

Zanesville, OH- Every 65 seconds, someone in the U.S. receives a troubling diagnosis.  Alzheimer’s disease, which has no cure ...

In the early stages of Alzheimer’s disease, people may have trouble following conversations, repeat themselves, or struggle ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life expectancy also brings an increase in the number of diseases, ...